4YFN

GSK: science, technology and talent to get ahead of disease together

Doors Open
14:30
When

Mon, 27 Feb: 15:00 - 19:00 CET

FREE ACCESS

Physical
Location

Partner Lab – Discovery Area, Hall 8.1

Share

Loading…

Session Description

There’s never been a time when science and technology have formed such a powerful union as they do right now. We’re able to identify new targets using AI/ML in an unprecedented way to anticipate treatment prognosis. We’re also able to use more approaches than ever before to discover more efficient ways to serve patients and healthcare professionals. 

Discover in this session how GSK is incorporating technology and how it is developing science to get ahead of disease. 

We will talk about digital twins, digital therapeutics, AI/ML to help patients, lab efficiency, immersive training, and how the ecosystem is evolving to bring hope to the table. Are you in?

15.00-15.10
KEYNOTE: GSK: science and technology to provide hope

Eloy Gómez Palomo, VP & Oncology Director - GSK

15.10-15.30

KEYNOTE: Digital Twins: how are we using advanced technology to accelerate development?

Matt Harrison, VP Digital Sciences Vaccines - GSK

15.30-15.50
KEYNOTE: Digital Health: Data to power health impact at scale

Lisa Banks, VP Digital Health & Innovation - GSK

15.50-16.10

KEYNOTE: AI/ML for decision-making in Hematology

Dr. Adrián Mosquera, Hematologist at Santiago de Compostela Hospital

16.10-16.40
ROUNDTABLE: Partnering to provide cutting-edge technology to the hematology lab

Moderator: Miguel Ferreira, Hematology Franchise Lead - GSK

Speakers:

Dra. Luz Muñoz, Director of Clinical Laboratory, Parc Taulí University Hospital

Miguel Luengo-Oroz, CEO, Spotlab


16.40-17.00
BREAK


17.00-17.30
ROUNDTABLE: OncoGYN, when technology partners with hospitals to deliver what patients need

Moderator: Sara A. Pedraz, Innovation Lead - GSK

Speakers:
Dra. Beatriz Pardo
, Director Oncologist, Catalan Institute of Oncology
Dr. Jordi Ponce, Head of Gynecology, Bellvitge University Hospital


17.30-18.20
e-llas: collaboration to move from cancer to hope
Manuela Doménech, Oncology Franchise Lead - GSK
Sara A. Pedraz, Innovation Lead - GSK


ROUNDTABLE:

Moderator: Manuela Doménech, Oncology Franchise Lead - GSK

Speakers:
Carlos Pérez
, Telefónica
Jennifer Verhelle, Cumlaude Lab
Marisa Cots, AMOH


18.20-18.30
CLOSURE
: Cristina Henríquez de Luna, SVP & GM Spain, Israel, Portugal - GSK
 

 

Doors Open: 14:30

Session Speakers


Similar Sessions